Literature DB >> 25496398

Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission.

T A Duong1, N de Prost, S Ingen-Housz-Oro, A-S Carrié, F Zerah, L Valeyrie-Allanore, M Bagot, O Chosidow, J-C Roujeau, P Wolkenstein, B Maitre.   

Abstract

BACKGROUND: Acute-stage specific bronchial epithelial detachment has been described in 27% of patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
OBJECTIVES: To assess the pulmonary function of patients with SJS/TEN after remission.
METHODS: Analysis of pulmonary function tests (PFTs) performed during the usual follow-up of patients with SJS/TEN managed in a referral centre from April 2007 to January 2010.
RESULTS: Of 58 patients admitted, 32 underwent PFTs (17 male, 15 female). The median time from the acute stage to PFTs was 3 months (interquartile range 1-18). Three patients had grade 2 dyspnoea. Eighteen patients (56%) had abnormal PFTs, including 13 patients (41%) with moderately altered diffusion capacity for carbon monoxide (DLCO ) normalized by the alveolar volume (VA) (giving the ratio KCO , which equals DLCO /VA) and five patients with decreased total lung capacity. No airway obstruction was observed. Patients with decreased KCO had higher initial detached body surface area than others (30% vs. 10%, P = 0·006), as did those with decreased DLCO (25% vs. 10%; P = 0·054). There were correlations between detached body surface area and both KCO (r = -0·41, P = 0·026) and DLCO (r = -0·47, P = 0·011). Among 10 patients with decreased KCO on the first PFT, eight patients had a sustained decrease in KCO on a second PFT.
CONCLUSIONS: More than half of patients with SJS/TEN displayed abnormalities on PFTs, mainly diffusion impairment, which was associated with higher initial skin surface detachment. These abnormalities were mostly asymptomatic and remained stable over time.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25496398     DOI: 10.1111/bjd.13505

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  [Severe skin reactions due to new medications].

Authors:  M Mockenhaupt; M Paulmann
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

Review 2.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

3.  The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.

Authors:  Liang-Ping Ye; Cheng Zhang; Qi-Xing Zhu
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

4.  Acute lung injury in mechanically ventilated patients with epidermal necrolysis: an exposed-unexposed retrospective cohort study.

Authors:  S Lalevée; J Catano; S Ingen-Housz-Oro; M Surenaud; J Tran Van Nhieu; F Schlemmer; I Bendib; A Mekontso-Dessap; S Hue; N de Prost
Journal:  Burns Trauma       Date:  2020-12-08

5.  Pneumonia caused by toxic epidermal necrolysis.

Authors:  Dominic Doyle; Amy Long; Desmond M Murphy
Journal:  Respirol Case Rep       Date:  2022-09-29

6.  Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.

Authors:  Rannakoe J Lehloenya
Journal:  Front Med (Lausanne)       Date:  2022-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.